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Current day concentrations of ambient air pollution have been associated with a range of adverse health effects,
particularly mortality and morbidity due to cardiovascular and respiratory diseases. In this review, we summarize the
evidence from epidemiological studies on long-term exposure to fine and coarse particles, nitrogen dioxide (NO2)
and elemental carbon on mortality from all-causes, cardiovascular disease and respiratory disease. We also
summarize the findings on potentially susceptible subgroups across studies. We identified studies through a search
in the databases Medline and Scopus and previous reviews until January 2013 and performed a meta-analysis if
more than five studies were available for the same exposure metric.
There is a significant number of new studies on long-term air pollution exposure, covering a wider geographic area,
including Asia. These recent studies support associations found in previous cohort studies on PM2.5. The pooled
effect estimate expressed as excess risk per 10 μg/m3 increase in PM2.5 exposure was 6% (95% CI 4, 8%) for
all-cause and 11% (95% CI 5, 16%) for cardiovascular mortality. Long-term exposure to PM2.5 was more associated
with mortality from cardiovascular disease (particularly ischemic heart disease) than from non-malignant respiratory
diseases (pooled estimate 3% (95% CI −6, 13%)). Significant heterogeneity in PM2.5 effect estimates was found
across studies, likely related to differences in particle composition, infiltration of particles indoors, population
characteristics and methodological differences in exposure assessment and confounder control. All-cause mortality
was significantly associated with elemental carbon (pooled estimate per 1 μg/m3 6% (95% CI 5, 7%)) and NO2
(pooled estimate per 10 μg/m3 5% (95% CI 3, 8%)), both markers of combustion sources. There was little evidence
for an association between long term coarse particulate matter exposure and mortality, possibly due to the small
number of studies and limitations in exposure assessment. Across studies, there was little evidence for a stronger
association among women compared to men. In subjects with lower education and obese subjects a larger effect
estimate for mortality related to fine PM was found, though the evidence for differences related to education has
been weakened in more recent studies.
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Background
There is growing evidence of mortality effects related to
long-term exposure (i.e., exposures of a year or more) to
ambient air pollution [1-3]. Cardiovascular effects of
short- and long-term exposure to particulate matter air
pollution focusing on PM2.5 have recently been compre-
hensively reviewed [4,5]. Experimental and epidemiological* Correspondence: g.hoek@uu.nl
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reproduction in any medium, provided the orstudies in the recent decade have significantly increased
our knowledge of mechanisms that could plausibly explain
the associations observed in epidemiological studies be-
tween ambient air pollution and mortality [4].
Most studies have reported associations linked to par-
ticulate matter, often represented by the mass concentra-
tion of particles smaller than 10 μm (PM10) or 2.5 μm
(PM2.5). In many urban areas, motorized traffic emis-
sions are an important source of ambient particles and
gaseous pollutants such as nitrogen oxides (NO2 and
NO). Exposure contrasts related to traffic emissions are
usually poorly represented by the concentration of PM10td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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centration of these particle metrics from other sources
[6,7]. However, there are more specific markers for traf-
fic related air pollution, which include elemental carbon
and ultrafine particles number [7-10]. Janssen and co-
workers recently demonstrated that health impact as-
sessments of traffic-related pollutants based upon PM2.5
seriously underestimated the health risks compared to
an assessment based upon elemental carbon [7]. There
is also growing evidence of health effects related to
ultrafine particles [8,9]. Finally, the effects of coarse par-
ticles (the particle fraction between 2.5 and 10 μm) have
attracted renewed attention [11]. Emission controls for
road traffic have now substantially reduced tailpipe
emissions, and therefore non-tailpipe emissions includ-
ing engine crankcase emissions (combusted lubricating
oil), road, tire and brake wear are becoming increasingly
important. A recent study in the Netherlands found simi-
lar increases of concentrations in major roads compared
to urban background for metals related to break and tire
wear (Cu, Zn) as for soot and ultrafine particles which are
due to tailpipe emissions [10] . In a review of the limited
literature, coarse particles were associated with short-term
effects on mortality and hospital admissions, but no evi-
dence was found for long-term exposure effects [11]. The
number of studies on long-term coarse particle exposure
reviewed was small however at the time.
The aim of the current review is to evaluate the epi-
demiological evidence for cardiovascular and respiratory
mortality effects of long-term exposure to fine particu-
late matter, including a meta-analysis. We focused on
epidemiological studies of mortality, as experimental
studies and mechanisms of effect have been discussed in
detail previously [4]. The American Heart Association
review [4] is updated with a significant number of new
studies published in 2009 – 2012. We further include
more pollutants in the review, specifically NO2, elemen-
tal carbon and coarse particles. We evaluated the find-
ings on potentially susceptible subgroups across studies
of PM2.5. In addition, we have included the studies on
more specific cardiovascular causes of death, especially
fatal myocardial infarction and stroke.
Methods
We performed a search in the databases Medline and
Scopus with the search terms air pollution, cohort,
and mortality until January 2013. We supplemented
the search with studies included in the review by
Brook and co-worker [4] and by browsing the refer-
ence lists of identified papers. In case more than five
studies were identified, we performed a meta-analysis.
We tested for heterogeneity of cohort-specific effect
estimates and obtained combined effects estimates,
using random effects methods of DerSimonian andLaird [12]. The I2 statistic was calculated as a measure of
the degree of heterogeneity across studies [13]. I2 ranges
from 0 to 100% and can be interpreted as the variability of
study-specific effect estimates attributable to true between
study effects. From some studies multiple papers were
available such as the Six Cities study [14-16]. In the
meta-analysis we used only the most recent paper,
which had longer follow-up. We only included studies
in the quantitative meta-analysis that directly provided
PM2.5 exposure estimates. For NO2 we only included
studies which accounted for intra-urban spatial vari-
ation using e.g. dispersion models, land use regression
models or spatial interpolation. We used STATA ver-
sion 10 (Stata Corp, College Station, Texas) for meta-
analysis. Effect estimates are presented as excess risks
expressed per 10 μg/m3 contrast in exposure, except
elemental carbon for which risks were expressed per
1 μg/m3.
PM2.5 and all-cause and cardiovascular mortality
Table 1 and Figures 1 and 2 summarize the studies on
long-term air pollution exposure and all-cause and car-
diovascular mortality using PM2.5 or PM10 as exposure
metric [14-39]. Most but not all studies report signifi-
cant associations between PM2.5 and all-cause mortality.
Since the publication of the authoritative American
Heart Association Scientific Statement, sixteen new co-
hort studies were published between 2009 and January
2013. These studies were often performed in more se-
lected groups e.g. female teachers [27,36] or male truck
drivers [32]. The geographic range has also been ex-
panded significantly with several new studies from
Japan and China now published. Another tendency is
the publication of large studies based upon large
population samples (e.g. census), with often less infor-
mation on confounding variables such as individual
smoking habits. Large cohort studies have used neigh-
borhood socio-economic status and co-morbidities
strongly associated with smoking as proxies for actual
smoking data [26,38]. Effect estimates differed sub-
stantially across studies, with most studies showing
less than 10% increase in mortality for an increment
of 10 μg/m3 PM2.5. The random effects summary esti-
mate for the percent excess risk per 10 μg/m3 PM2.5
for all-cause mortality was 6.2% (95% CI: 4.1 – 8.4%).
A formal test of heterogeneity was statistically signifi-
cant, with an I2 value of 65% indicating moderate het-
erogeneity. I2 can be interpreted as the variability in
effect estimates due to true between study variability
and not chance [13]. The random effects summary ef-
fect estimate for cardiovascular mortality was 10.6%
(95% CI 5.4, 16.0%) per 10 μg/m3. Thus, the overall
effect estimates were larger for cardiovascular than for
all-cause mortality. This pattern was found in most of
Table 1 Summary of effect estimates (excess risk per 10 μg/m3) from cohort studies on particulate matter (PM10 or PM2.5) and mortality from all causes and
cardiovascular diseases
Study Study population Follow-up period Pollutant Conca (μg/m3) Spatial scaleb % change in risk (95% CI)
in mortality associated with
a 10 μg/m3 increase PM
References
All cause Cardiovascularc
Harvard six cities 8111 adults in six US cities 1976 - 1989 PM2.5 18 (11–30) City 13(4, 23) 18 (6, 32) [15]
Harvard six cities 8096 adults in six US cities 1979 -1998 PM2.5 15 (10–22) City 16 (7, 26) 28 (13,44) [14]
Harvard six cities 8096 adults in six US cities 1974 - 2009 PM2.5 16 (11–24) City 14 (7, 22) 26 (14, 40) [16]
American Cancer Society (ACS) study 552, 800 adults from 51 US cities 1982 - 1989 PM2.5 18 (9–34) City 26 (8, 47) NA [17]
ACS study 500,000 adults from 51 US cities 1982 -1998 PM2.5 18 (4) City 6 (2, 11) 9 (3, 16)
c [18]
ACS sub-cohort study 22,905 subjects in Los Angeles area 1982 - 2000 PM2.5 (~9 – 27) Zip code (Int) 17 (5, 30) 26 (1, 60)
c [19]
German cohort 4752 women in Ruhr area 1985 – 2003 PM10 44 (35–53) Address (near) 12 (−9, 37) 52 (8, 114) [20]
German cohort 4752 women in Ruhr and surrounding area 1985 - 2008 PM10 44 (35–53) Address (near) 22 (6, 41) 61 (26, 104) [21]
Women’s Health Initiative
Observational Study
65,893 postmenopausal women from 36 US
metropolitan areas
1994-1998 PM2.5 14 (3–28) Zip code (near) NA 76 (25,147) [22]
Netherlands Cohort Study 120, 852 subjects from Netherlands 1987 -1996 PM2.5 28 (23–37) Address (LUR) 6 (−3, 16) 4 (−10, 21) [23]
Nurses’ Health Study 66,250 women from the US north eastern
metropolitan areas
1992-2002 PM10 22 (4) Address (LUR) 11 (1,23) 35 (3, 77) [24]
Nurses’ Health Study 66,250 women from the US north eastern
metropolitan areas
1992-2002 PM2.5 14 (6–28) Address (LUR) 26 (2, 54) NA [25]
Medicare national cohort 13.2 million elderly Medicare recipients across
the USA
2000 - 2005 PM2.5 13 (4) Zip code (Mean) 4 (3, 6)
d [26]
California teachers study 45,000 female teachers 2002 -2007 PM2.5 18 (7–39) Address (near) 6 (−4, 16) 19 (5, 36)
c [27]
Swiss national cohort National census data linked with mortality 2000 - 2005 PM10 19 (>40)
e Address (Disp) NA −1 (−3, 0) [28]
Health professionals follow-up study 17,545 highly educated men in the midwestern
and northeastern US
1989 – 2003 PM2.5 18 (3) Address (LUR) −14 (−28,2) 3 (−17, 26) [29]
Vancouver cohort 452,735 Vancouver residents 45–85 yr 1999 – 2002 PM2.5 4 (0 – 10) Address (LUR) NA 7 (-14, 32) [30]
China nat. hypertension survey 70,497 men and women 1991 - 2000 TSP 289 (113–499) City 0.3 (0, 1) 1 (0, 2) [31]
US trucking industry cohort 53,814 men in the US trucking industry 1985 -2000 PM2.5 14 (4) Address (near) 10 (3, 18) 5 (−7, 19) [32]
Chinese retrospective cohort study 9,941 adults from five districts of Shenyang
city
1998 -2009 PM10 154 (78–274)
f District (mean) 53 (50, 56) 55 (51, 60) [33]
Canadian national cohort 2.1 million nonimmigrant Canadians . > 25 yr 1991 - 2001 PM2.5 9 (2 – 19) Enumeration area,
N = 45710 (satellite)
10 (5, 15) 15 (7, 24) [34]
New Zealand Census mortality study 1.06 million adults in urban areas from 1996
census
















Table 1 Summary of effect estimates (excess risk per 10 μg/m3) from cohort studies on particulate matter (PM10 or PM2.5) and mortality from all causes and
cardiovascular diseases (Continued)
California teachers study 101,784 female teachers 1997- 2005 PM2.5 16 (3–28) Address (Inter) 1 (−5, 9) 7 (−5, 19) [36]
Nippon data cohort 7,250 adults > 30 yr throughout Japan 1980 - 2004 PM10 <27 - > 43 District (near) −2 (−8, 4) −10 (−19, 0) [37]
Rome longitudinal study 1,265,058 adults from Rome 2001 - 2010 PM2.5 23 (7 – 32) Address
(DISP, 1 km grid)
4 (3, 5) 6 (4, 8) [38]
a Mean with minimum – maximum in parentheses (μg/m3). One number in parentheses is standard deviation.
b Spatial scale of exposure assignment, in parentheses exposure assignment method. City = average of monitors within the city; Near = nearest monitor concentration; LUR = land use regression; Disp = dispersion
modeling; Inter = interpolation.
c Cardio-pulmonary mortality reported if cardiovascular mortality not available.
d Combining the estimates from the three regions of the USA.
e Median and 90th percentile reported.
f Very high pollution levels that changed significantly during follow-up changing the ranking of the five districts.
















NOTE: Weights are from random effects analysis










































Figure 1 Meta-analysis of the association between PM2.5 and all-cause mortality (Relative risk per 10 μg/m
3). Overall uses random effects.
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Dutch cohort study [23], the US trucking industry co-
hort study [32] and a national cohort study from New
Zealand [35]. Significant and large heterogeneity of ef-
fects was found across studies, with an I2 statistic of
61%. After excluding the Miller study [22], moderate
heterogeneity remained (I2 = 40%). Overall, the new
studies have supported an association between PM2.5
and mortality first identified in the US Six City and
ACS studies. It is of interest to note that the weight of
the ACS study in the combined effect estimate is 12%
for all-cause mortality, documenting that the combined
estimate does not rely on one or two studies. Further-
more, effect estimates from the three large population
cohorts without individual smoking data [26,34,38] were
not higher than those from the individual cohort studies.
An important question is what the explanation is for
the observed heterogeneity of effect estimates. Differ-
ences in study population, exposure assessment, pollu-
tion mixture, study period, outcome assessment, and
confounder control could have contributed to these
differences.
Effect modification
Differences in the fraction of susceptible subjects may
have contributed to the observed differences. Brook [4]
suggested that women might be more susceptible to am-
bient air pollution. The studies with higher PM effectestimates, particularly the WHI-study have indeed been
performed in women only. However, it is problematic to
draw conclusions about susceptible subgroups based
upon between-study comparisons as multiple factors dif-
fer between studies. A comparison of PM effect estimates
between men and women within studies does not provide
clear evidence that women have a stronger response
(Table 2). The findings from the AHSMOG are difficult to
interpret, with higher effects in men in the larger earlier
study [40] and larger effects in women in the smaller co-
hort with longer follow-up [41]. The larger effect estimate
for BC for men in a Canadian study [30] has to be
interpreted with care, because of the lack of data on a var-
iety of important covariates, including individual smoking
data, though the authors argue that smoking likely has not
confounded the associations with mortality. In the French
PAARC study, effect estimates for the evaluated pollutants
(TSP, BS and NO2) were similar among men and women
[42]. There is also only weak evidence that effect estimates
are larger among never-smokers, though in all evaluated
studies a (borderline) significant association was found in
never-smokers (Table 2). Associations in current smokers
were more variable across the studies, consistent with the
larger ‘noise’ generated by smoking. In all four studies,
PM2.5 effect estimates were higher for those with the low-
est education and there was little indication of an associ-
ation in those with higher education. The absence of an
association in the (highly educated) Health professionals
NOTE: Weights are from random effects analysis







































Figure 2 Meta-analysis of the association between PM2.5 and cardiovascular mortality (Relative Risk per 10 μg/m
3). Overall uses
random effects.
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in the French PAARC study, effect estimates for Black
Smoke were very similar across educational strata, with
significant effect also found in those with a university de-
gree [42]. Furthermore the PM2.5 effect estimates (excess
risks) in an extended analysis of the ACS differed less than
originally reported: 8.2%, 7.2 and 5.5% per 10 μg/m3 for
subjects with low, medium and high education respect-
ively [43]. If confirmed in further studies, it is likely that
multiple life style related factors may play a role in the
stronger effects observed in less-educated subjects. These
may include dietary factors such as lower fruit and anti-
oxidant intake [23], higher risk of obesity or other pre-
existing diseases, higher actual exposures than assumed in
the studies, lack of air conditioning and possibly inter-
action with other risk factors such as poorer housing con-
ditions e.g. moisture.
In two studies, PM2.5 effect estimates were substantially
higher among subjects with high body mass index [22,24].
It is likely that subject characteristics might explain part
of the variability of air pollution effect estimates across
studies where subgroup analyses are limited by power to
detect differences. Hence, further research is required to
study the effects of air pollution on women, smokers, obese
participants, and diabetes mellitus with better measure-
ment of the exposures. Gene-environment interactions
have been shown for the (short-term) air pollution effects
on inflammation markers [44,45] Inflammation likely playsan important role in the mechanism of cardiovascular
events [3,4]. Gene-environment interactions have not yet
been studied in the framework of mortality cohort studies.
Exposure issues
One of the important sources of variability of effect
estimates between studies is likely related to exposure
definition and misclassification. While the most im-
portant environmental predictor to consider is actual
individual-level exposure to ambient particles, which pre-
sumably drives the health effects, most studies have used
outdoor concentrations at sites distant to the participant’s
precise location. The use of outdoor exposures leads to ex-
posure misclassification. In the cohort studies, exposure
has been characterized by the outdoor concentration at
the city level based upon central site monitoring or the
nearest monitor, or modeling at the individual address.
Table 1 shows that the spatial scale of assessment and ex-
posure assessment method varied significantly across
studies, probably contributing to differences in effect esti-
mates. Differences in pollution range across studies
(Table 1) may have contributed as well. These exposure
estimates do not take into account time activity patterns
such as time spent in the home or in traffic and factors af-
fecting infiltration of particles indoors. There is a large lit-
erature documenting the importance of air exchange rate
on infiltration of particles indoors. Importantly, these fac-
tors may differ between homes within a study area and
Table 2 Effect modification of the effect (excess risk per 10 μg/m3) of PM2.5 on cardiovascular mortality
Subgroup ACS [18]a NLCS [23] Harvard six city [43] Nurses health [24] WHI [22] AHSMOG [40] AHSMOG [41]
Sex
Men 5 (0, 11) 3 (−5, 12)b 33 (8, 63)a NA NA 4 (−3,11) −10 (−−24, 5)
Women 6 (0, 12) 7 (0, 14) 20 (−6, 53) −3 (−9, 2) 42 (6, 90)
Smoking status
Never 6 (1, 12) 13 (−4, 32) 36 (2, 82) 83 (20, 179) 18 (−1, 40) NA NA
Former 5 (0, 11) −4 (−17, 13) 29 (−3, 72) 22 (−18, 83) 21 (1, 52)
Current 4 (−2, 11) 3 (−10, 19) 35 (94, 74) −12 (−48, 48) 68 (6, 166)
Education
Low 11 (6, 18) 20 (−10, 70)a 45 (13, 85) 40 (11, 75) NA NA
Medium 6 (1, 13) 2 (−16, 24) 30 (−2,73) 33 (14, 55)
High 1 (−3, 6) −10 (−35, 20) −3 (−29, 34) 11 (−6, 31)
Body mass index
Non-Obese NA NA NA 8 (−24, 52) −1 (−10, 29)c NA NA
Obese 99 (23, 222) 35 (12, 64)c
a Read from graph.
b natural-cause mortality.
c for BMI < 22.5, continuous trend observed NA = not available.
Hoek et al. Environmental Health 2013, 12:43 Page 7 of 15
http://www.ehjournal.net/content/12/1/43between study areas in different climates. In a study of
short-term effects, PM10 effects on hospital admissions
were larger in US cities with lower% of air conditioning,
related to higher particle infiltration rates [46]. The impact
of air conditioning use has not been investigated yet in the
framework of cohort studies. In the Multiethnic study of
Atherosclerosis Air study, indoor-outdoor measurements
have been performed to adjust the exposure estimates
[47,48] and each participant provides time-activity infor-
mation to weight exposures between time spent indoors
and outdoors. Evidence for the importance of time activity
patterns was obtained in the US truckers study, showing
higher ambient PM2.5 effect estimates in the population
excluding long-haul drivers who spend more time away
from home [32]. Other factors could however also explain
the higher effect estimated after excluding long-haul
drivers. In the WHI study, effect estimates tended to be
higher for subjects spending more than 30 minutes out-
doors [22]. In a validation study in the Netherlands, the
contrast of personal soot exposure for adults living on a
major road compared to those living at a background loca-
tion, was larger for those spending more time at home
[49]. Because of the reliance on ambient exposure esti-
mates, it is not surprising that some heterogeneity in effect
estimates across studies is found.
Differences in particle composition or contributing
sources very likely explain some of the heterogeneity in ef-
fect estimates, as was observed for short-term mortality
and hospital admission studies of PM2.5 and PM10 [50-53].
For a comprehensive review we refer to the recent
evaluation made by the World Health Organization(http://www.euro.who.int/en/what-we-do/health-topics/
environment-and-health/air-quality/publications/2013/
review-of-evidence-on-health-aspects-of-air-pollution-
revihaap). Particle composition effects have not been
systematically investigated in cohort studies with the ex-
ception of the California teacher’s study [27]. In a recent
review it was shown that on a per microgram per m3
basis, mortality effect estimates were about 10 times lar-
ger for EC than for PM2.5 [7]. Hence, in locations with
higher levels of primary combustion particles we could
expect higher PM2.5 effects. In the next section, evi-
dence on EC is further discussed.
A further important issue is for which period exposure is
characterized. Air pollution data may not be available for
the entire follow-up period. As an example in the ACS
study, PM2.5 data were available at the start and end of
follow-up [18]. When significant (often downward) trends
in pollution occur with changing (often decreasing) spatial
contrasts in the study, bias may occur in the estimated as-
sociation between pollution and mortality. The follow-up
study from the Harvard Six City study [14] and two stud-
ies in potentially at-risk populations [54,55] suggested that
the relevant exposure for cardiovascular effects may be
the exposure in the past few years. These authors con-
clude that it does not take decades to bridge the gap
between the short- and long-term exposure effect esti-
mates, consistent with the effect of intervention studies
showing reductions in mortality in the year after the
intervention [54,55]. These studies [54,55] have made
use of long-term temporal contrast within cities
adjusting for secular trends. PM effect estimates were
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spatial contrasts.
A further temporal issue in studies that use land use
regression models for exposure assessment is that these
models often are based upon current measurement cam-
paigns and linked to health outcomes that occurred in
the past. Three studies in the Netherlands, Rome (Italy)
and Vancouver (Canada) have shown that for periods of
about 10 years current LUR models predicted historic
spatial contrasts well [56-58]. Even when concentrations
have decreased over time, spatial contrasts often remain
stable. Spatial contrasts may not be stable in areas with
rapid economic development as indicated in one of the
Chinese cohort studies in which the ranking of study
areas changed during follow-up [33,59]. Even when the
ranking of subjects is not changed, the quantitative
spatial contrast in a study area may have changed, e.g.
because the difference between major roads and back-
ground locations has decreased in time. Changed spatial
contrasts will affect the estimated slope of the mortality
pollution association [18,56]. Moving of subjects may
further complicate the assessment.
An important question to address for the traffic pollu-
tion studies is potential confounding by road traffic noise,
which has been shown to be related to cardiovascular
disease including MI as well. A few studies have at-
tempted to disentangle traffic-related air pollution
and noise [60-62]. These studies found moderate cor-
relations between air pollution and noise. The three
studies differed somewhat in their findings of independent
air pollution and noise effects. More work is needed in
this area.Coarse particles and elemental carbon
Table 3 presents studies that have used elemental carbon
or coarse PM as the exposure metric. Table 3 illustrates
that there is no evidence that long-term exposure to
coarse PM is related to mortality. In three of the four co-
hort studies that reported no significant association with
coarse PM, significant associations with PM2.5 were found
[18,25,63]. However, exposure assessment for coarse parti-
cles is more challenging than for PM2.5 because of the in-
fluence of local sources, hence central site monitors are
likely to have greater errors in representing residential
concentrations. It is therefore possible that with more
spatially resolved exposure assessment methods such as
land use regression models or dispersion models, potential
long-term exposure effects will be detected. The California
Teacher’s study did not evaluate coarse PM and did not
find significant associations between all-cause mortality
and elemental concentrations of Si, Fe and Zn, elements
abundant in coarse particles, but did report an association
between Si and ischemic heart disease [27].Consistently, the summary estimate for PM10 was
smaller than for PM2.5 with a summary effect estimate
per 10 μg/m3 of 3.5% (95% CI 0.4%, 6.6%) with signifi-
cant heterogeneity (I2 = 69%) of the studies included in
Table 1, excluding the because of changing spatial pat-
terns difficult to interpret Chinese retrospective study
[33]. The PM10 analysis was added as several studies
only report PM10.
Effect estimates for EC were very consistent across
studies [23,27,30,42,64-67]. The random effects sum-
mary estimate for all-cause mortality per 1 μg/m3 EC
was 6.1% (95% CI 4.9%, 7.3%), with highly non-signifi-
cant heterogeneity of effect estimates (I2 = 0%). Most of
the included studies assessed EC exposure at the city-
scale [27,64] which represents variation in city back-
ground but does not account for small-scale variation
related to proximity to major roads. Many studies have
documented significant intra-urban contrasts for EC, re-
lated to especially major roads [7]. Most likely EC and
NO2 should be considered representatives of the com-
plex mixture of traffic-related air pollution, rather than
the only components causally associated with mortality.
There is fairly consistent evidence of associations of
mortality with nitrogen dioxide (Table 4). The random
effects summary estimate for all-cause mortality per
10 μg/m3 for NO2 was 5.5% (95% CI 3.1%, 8.0%), with
significant and large heterogeneity of effect estimates
(I2 = 73%). In this analysis, the Chinese study [33] was not
included as exposure was assessed at the district level.
Inclusion of the essentially null findings of the ACS study-
excess risk of 0.3% (95% CI −0.8, 1.3%)- resulted in an only
slightly smaller combined estimate of 4.7% (95% CI 2.4,
7.1%). In the ACS study, intra-urban variation was also
not accounted for. As traffic-related air pollution varies on
a small spatial scale, it is even more critical to assess ex-
posure on a fine spatial scale such as the residential ad-
dress than for PM2.5.
Specific cardiovascular causes of death
Table 5 shows associations between ambient air pollution
and mortality from ischemic heart disease or myocardial
infarction (MI), including studies based upon death certif-
icates, more detailed studies using registry data, or ideally
cohort studies with epidemiological review of medical re-
cords, allowing more precise identification of disease inci-
dence. Several case–control studies based upon M.I.
registries or epidemiological studies with clinical review
have found associations between NO2 and fatal M.I. but
not non-fatal M.I. [72-74]. Thus far, the finding of associa-
tions for fatal MI only was interpreted as an evidence that
air pollution particularly affects the frail, or acts to ag-
gravate a disease progression caused by other factors. On
the other hand, it is also possible that the outcomes of
ischemic heart diseases are misclassified and combined
Table 3 Summary of effect estimates (excess risk per 10 μg/m3) from cohort studies on coarse particulate matter and elemental carbon (per 1 μg/m3) and
mortality from all causes and cardiovascular diseases
Study name Study design Follow-up period Pollutant Conca (μg/m3) Spatial scaleb % change in risk




ACS study 500,000 adults 51 US cities 1982 - 1998 PM2.5–15 19 (6) City 1 (−2 3) 2 (−2, 5)* [18]
AHSMOG study 3769 California seventh-day Adventists 1977 – 1992 PM2.5–15 27 (4 – 44) Address (Inter) 5 (−8, 20) NA [63]
Nurses’ Health Study 66,250 women from US north eastern
metropolitan areas
1992- 2002 PM2.5–10 8 (0 – 27) Address (LUR) 3 (−11, 18) NA [25]
Health professionals
follow-up study
17,545 highly educated men in the
midwestern and northeastern US
1989 – 2003 PM2.5–10 10 (3) Address (LUR) −10 (−22, 4) 8 (−10, 29) [29]
EC
Netherlands Cohort Study 120, 852 subjects from Netherlands 1987 - 1996 BSe 17 (9–36) Address (LUR) 5 (0, 11) 4 (−5, 13) [23]
ACS study (extended) 500,000 adults 51 US cities 1982 – 1998 EC IQR = 0.31 City 6 (1, 11) 11 (3, 19) [64]
Worcester MI survivors 3,895 MI patients 1995 - 2005 EC 0.4 (0.1 – 0.9) Address (LUR) 2 (−7, 11)d NA [65]
15 (3, 29)
Vancouver cohort 452,735 Vancouver residents 45–85 yr 1999 – 2002 BC 1.5 (0–5) Address (LUR) NA 6 (3, 9) [30]
PAARC 14,284 adults in 24 French areas 1974 – 1998 BS 44 (18–77) Address (near) 7 (3, 10) 5 (−2, 12) [42]
Veteran’s study 70,000 male US veterans 1997 – 2001 EC 0.6 (0.1 – 2.0) County (mean) 18 (5, 33) NA [66]
California teachers study 45,000 female teachers 2002 -2007 EC 1.1 (0.2 – 2.4) Address (near) 3 (−11,19) 11 (−9, 36) [27]
Two Scotch cohorts 15, 402 and 7,028 adults from West-central
and central Scotland
1972 - 1998 1970 - 1998 BS 19 LUR + temporal 5 (1,9) 7 (0, 13) [67]
a Mean with minimum – maximum in parentheses (μg/m3). One number in parentheses is standard deviation.
b Spatial scale of exposure assignment, in parentheses exposure assignment method. City = average of monitors within the city; Near = nearest monitor concentration; LUR = land use regression; Disp = dispersion
modeling; Inter = interpolation.
c Cardio-pulmonary mortality reported if cardiovascular mortality not available.
d HRs for first two years after MI and after the first two years of survival.
e BC (Black Carbon), BS (Black Smoke) and EC (Elemental carbon) are different markers used to assess soot. Increases consistent with a 1 μg/m3 increase in EC were used [7].
















Table 4 Summary of cohort studies on NO2 and mortality from all causes and cardiovascular diseases (excess risk per 10 μg/m
3)
Study name Study population Follow-up
period
Pollutant Conca (μg/m3) Spatial scaleb % change in risk (95% CI)
in mortality per 10 μg/m3
References
All causes Cardiovascular
Oslo cohort 16,209 men in Oslo, Norway 1972 – 1998 NOx 11 (1 – 168) Address (DISP) 8 (6,11) NA [68]
Netherlands Cohort Study 120, 852 subjects from Netherlands 1987 -1996 NO2 37 (15–67) Address (LUR) 8 (0, 16) 7 (−6, 21) [23]
German cohort 4752 women in Ruhr and surrounding area 1985 – 2003 NO2 39 (20 – 60) Address (near) 11 (1,21) 36 (14, 63) [20]
German cohort 4752 women in Ruhr and surrounding area 1985 – 2008 NO2 39 (20 – 60) Address (near) 11 (4,18) 32 (18, 47) [21]
PAARC 14,284 adults in 24 French areas 1974 – 1998 NO2 20 (12 – 32) Address (near) 14 (3, 25) 27 (4, 56) [42]
China nat. hypertension survey 70,497 men and women 1991 - 2000 NOx 50 (20 – 122) City 2 (0, 3) 2 (1, 4) [31]
Vancouver cohort 452,735 Vancouver residents aged 45–85 yr 1999 – 2002 NO2 32 (15 – 58) Address (LUR) NA 5 (1, 9) [30]
DCH 52,061 adults in Copenhagen and Arhus 1993 - 2009 NO2 17 (11 – 60) Address (DISP) 8 (2, 13) 15 (3,27) [69]
US trucking industry cohort 53,814 men in the US trucking industry 1985 -2000 NO2 28 (14) Address (LUR) 5 (3, 7) 4 (0, 8) [32]
Chinese retrospective cohort study 9,941 adults from five districts of Shenyang city 1998 -2009 NO2 46 (18–78) District (mean) 145 (134, 158) 146 (131, 163) [33]
Rome longitudinal study 684,000 adults from Rome 2001 - 2006 NO2 45 (11) Address (LUR) 4 (3, 5) NA [56]
California Teachers study 101,784 female teachers 1997 -2005 NO2 67 (10 – 134) Address (Inter) −3 (−9, 4) −2 (−12, 9) [36]
Shizuoka elderly cohort 13,444 adults > 65 yr 1999 - 2006 NO2 25 (−19, 75) Address (LUR) 2 (−4, 8) 15 (3, 28) [70]
Ontario tax cohort 205, 440 adults in Toronto, Hamilton,Windsor 1982 – 2004 NO2 43 (8), 31 (6), 24 (5)
c Address (LUR) NA 8 (5, 11) [71]
Rome longitudinal study 1,265,058 adults from Rome 2001 - 2010 NO2 44 (13–75) Address (LUR) 3 (2, 3) 3 (2, 4) [38]
a Mean with minimum – maximum in parentheses (μg/m3). One number in parentheses is standard deviation.
b Spatial scale of exposure assignment, in parentheses exposure assignment method. City = average of monitors within the city; Near = nearest monitor concentration; LUR = land use regression; Disp = dispersion
modeling; Inter = interpolation.
c Mean (IQR) per city.
















Table 5 Summary of the studies on particulate matter and NO2 and mortality from specific cardiovascular diseases (excess risk per 10 μg/m
3)
Study name Pollutant Conca (μg/m3) Spatial scaleb % change in risk (95% CI) in mortality
associated with a 10 μg/m3 increase
References
IHD mortality M.I mortality Cerebrovascular mortality
ACS study PM2.5 17 (5) City 18 (14, 23) NA 2 (−5, 10) [39]
Oslo cohort NOx 11 (1 – 168) Address (DISP) 8 (3, 12) NA 4 (−6, 15) [68]
Women’s Health Initiative Study PM2.5 14 (3–28) Zip code 5 (near) 76 (25,147) NA NA [22]
Netherlands Cohort Study BS 17 (9–36) Address (LUR) 1 (−17, 22) NA 39 (−1, 94) [23]
Nurses’ Health Study PM10 22 (4) Address (LUR) 35 (3, 77) NA NA [24]
Nurses’ Health Study PM2.5 14 (6–28) Address (LUR) NA 102 (7, 278) NA [25]
California teachers study PM2.5 18 (7–39) Address (near) 55 (24, 93) NA NA [27]
Swiss national cohort PM10 19 (>40)
c Address (Disp) −1 (−3, 0) NA −1 (−2, 0) [28]
Health professionals follow-up study PM2.5 18 (3) Address (LUR) −2 (−30, 35) NA NA [29]
Canadian national cohort PM2.5 9 (2 – 19) Enumeration area,
N = 45710 (satellite)
30 (18,43) NA 4 (−7, 16) [34]
Californian Teachers study PM2.5 16 (3–28) Address (Inter) 20 (2, 41) NA 16 (−8, 46) [36]
Shizuoka elderly cohort NO2 25 (−19, 75) Address (LUR) 27 (2, 58) NA 9 (−6, 27) [70]
Nippon data cohort PM10 <27 - > 43 District (near) −8 (−27, 17) NA −14 (−26,1) [37]
DCH NO2 17 (11 – 60) Address (Disp) 7 (−9, 26) NA 6 (−14, 32) [69]
Ontario Tax cohort NO2 43 (8), 31 (6), 24 (5)
c Address (LUR) 9 (4, 14) NA −4 (−10, 5) [71]
Rome longitudinal study PM2.5 23 (7 – 32) Address (DISP, 1 km grid) 10 (6, 13) NA 8 (4, 13) [38]
M.I. registry studies
Stockholm NO2 14 (3 – 32) Address (DISP) NA 15 (−1, 33) NA [72]
Rome residents NO2 (<30 - > 60) Census block (LUR) NA 7 (2, 12) NA [73]
Stockholm residents NO2 12 (2 – 33) Address (DISP) NA 8 (5, 11) NA [74]
IHD = ischemic heart disease; MI = myocardial infarction. Fatal MI reported for registry studies. NA = not available.
a Mean with minimum – maximum in parentheses (μg/m3). One number in parentheses is standard deviation.
b Spatial scale of exposure assignment, in parentheses exposure assignment method. City = average of monitors within the city; Near = nearest monitor concentration; LUR = land use regression; Disp = dispersion
modeling; Inter = interpolation.
c Median and 90th percentile reported.
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http://www.ehjournal.net/content/12/1/43as composite outcomes, where fatal outcomes are cap-
tured more precisely [75]. Although there is increasing
evidence that air pollution is associated with markers of
early atherosclerosis, it is possible that air pollution will
affect the underlying biological processes that predispose
to atherothrombosis (which leads to MI and stroke) com-
pared to atherosclerosis [76,77]. Another explanation is
that the type of outcomes affected by pollution are those
that have higher case-fatality rates (e.g., arrhythmic sud-
den death has higher case-fatality rate than overall MI).
Fewer studies have evaluated cerebrovascular mortality.
In the Dutch cohort study and in the Women’s Health
Initiative Study, a strong association was found [22,23]. In
contrast, in the ACS study, the Norwegian cohort, and the
Swiss national cohort study no association was found
[28,39,68]. It is possible that poorer recording of cerebro-
vascular mortality on death certificates has contributed to
these inconsistencies. There is also some evidence from
ecological studies that air pollution may contribute to
stroke mortality [78,79].
Two studies have reported significant associations be-
tween particulate matter air pollution and dysrhythmia,
heart failure and cardiac arrest combined [39,60]. These
results are based upon smaller numbers of events, and
require large cohort studies for further verification. The
results are consistent with several studies documentingTable 6 Summary of the studies on air pollution and mortalit
Study Name Pollutant Conca (μg/m3) S
AHSMOG PM10 51 (17) A
ACS study PM2.5 17 (5) C
Oslo cohort NOx 11 (1 – 168) A
Harvard six cities PM2.5 15 (10–22) C
Netherlands Cohort Study PM2.5 28 (23–37) A
Netherlands Cohort Study NO2 37 (15–67) A
California Teachers study PM2.5 18 (7–39) A
China national. hypertension survey NOx 50 (20 – 122) C
China national. hypertension survey TSP 289 (113 – 499) C
US truckers study PM2.5 14 (4) A
US truckers study NO2 28 (14) A
California Teachers study PM2.5 16 (3–28) A
New Zealand Census study PM10 8 (0 – 19) C
Shenyang cohort study PM10 154 (78 – 274) D
Shenyang cohort study NO2 46 (18–78) D
Shizuoka elderly cohort NO2 25 (−19, 75) A
Two Scotch cohorts BS 19 L
Rome longitudinal study PM2.5 23 (7 – 32) A
a Mean with minimum – maximum in parentheses (μg/m3). One number in parenth
b Spatial scale of exposure assignment, in parentheses exposure assignment metho
concentration; LUR = land use regression; Disp = dispersion modeling; Inter = interpo
Studies adjusted for individual smoking except references [26,28,30,34,38,56].significant associations between short-term PM or NO2
exposure and mortality due to heart failure and dys-
rhythmia and defibrillator discharges [4,80].
Air pollution and respiratory mortality
Table 6 shows the effect estimates for respiratory mortal-
ity. In the two first US cohort studies, no association be-
tween PM2.5 and respiratory mortality was found [15,17].
In contrast to the findings of these US studies, strong as-
sociations were found in the Dutch cohort study [23], a
Norwegian study [68] and a Chinese study [59]. The ran-
dom effect pooled estimate per 10 μg/m3 for PM2.5 was
2.9% (95%CI −5.9, 12.6%), highly non-significant. The het-
erogeneity across studies was statistically significant
with an I2 statistic of 59%, indicating moderate hetero-
geneity. Associations for PM were weaker in the
Dutch and Chinese cohort study than with NO2 or
NOx. Respiratory mortality may be more related to
primary traffic-related pollutants than with long-range
transported particles, though further work is needed
to test this hypothesis. The smaller number of deaths
due to respiratory disease compared to cardiovascular
diseases, contributed to larger confidence intervals
within individual studies and larger variability of the
main effect estimates across studies. In time series
studies including several large multi-city studies in they from all respiratory disease (excess risk per 10 μg/m3)
patial scaleb % change in risk (95% CI)
in mortality per 10 μg/m3
References
ddress (Inter) 6 (−1, 15) [40]
ity −8 (−14, -2) [39]
ddress (DISP) 16 (6, 26) [68]
ity 8 (−21, 49) [14]
ddress (LUR) 7 (−25, 52) [23]
ddress (LUR) 12 (0, 26) [23]
ddress (near) 3 (−20, 34) [27]
ity 3 (0, 6) [31]
ity 0.3 (−1,1) [31]
ddress (near) 20 (−9, 60) [32]
ddress (LUR) 15 (1,31) [32]
ddress (Inter) 21 (−3, 52) [36]
ensus tract (Disp) 14 (5, 23) [35]
istrict (mean) 67 (60, 74) [59]
istrict (mean) 197 (169, 227) [59]
ddress (LUR) 19 (2, 38) [70]
UR + temporal 11 (−3, 28) [67]
ddress (DISP, 1 km grid) 3 (−3, 8) [38]
eses is standard deviation.
d. City = average of monitors within the city; Near = nearest monitor
lation.
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http://www.ehjournal.net/content/12/1/43USA and Europe, significant associations between
daily variations in PM and respiratory mortality were
found [1-4]. Expressed per 10 μg/m3 PM excess risks
of about 1% are typically reported for short-term ex-
posures, larger than for all-cause mortality [1-4]. In
contrast to cardiovascular disease, current evidence
therefore does not suggest an additional risk from
long-term exposure, possibly related to mortality dis-
placement [2,3]. More studies are needed to evaluate
long-term exposures on respiratory mortality more
thoroughly.
Conclusions
There is a significant number of new studies on long-
term air pollution exposure, covering a wider geographic
area, including Asia. These recent studies support asso-
ciations found in previous cohort studies on PM2.5. The
pooled effect estimate expressed as excess risk per
10 μg/m3 increase in PM2.5 exposure was 6% (95% CI 4,
8%) for all-cause and 11% (95% 5, 16%) for cardiovascu-
lar mortality. Long-term exposure to PM2.5 was more as-
sociated with mortality from cardiovascular disease
(particularly ischemic heart disease) than from non-
malignant respiratory diseases (pooled estimate 3% (95%
CI −6, 13%)). Significant heterogeneity in PM2.5 effect
estimates was found across studies, likely related to dif-
ferences in particle composition, infiltration of particles
indoors, population characteristics and methodological
differences in exposure assessment and confounder con-
trol. All-cause mortality was significantly associated with
elemental carbon (pooled estimate per 1 μg/m3 6% (95%
CI 5, 7%)) and NO2 (pooled estimate per 10 μg/m
3 5%
(95% CI 3, 8%)), both markers of combustion sources.
There was little evidence for an association between long
term coarse particulate matter exposure and mortality,
possibly due to the small number of studies and limita-
tions in exposure assessment. Across studies, there was
little evidence for stronger association among women
compared to men. Subjects with lower education and
obese subjects experienced larger mortality effect related
to fine PM, though the evidence for differences related
to education has been weakened in more recent studies.
Our review suggests several specific research questions.
Research into the reasons for the heterogeneity of effect
estimates would be extremely useful for health impact as-
sessment. Better exposure assessment including spatially
resolved outdoor exposures and more chemically spe-
ciated PM might in part be able to resolve the observed
heterogeneity. Chemical speciation would allow assessing
particles from different sources e.g. particles from com-
bustion sources and non-tailpipe emissions separately, a
question clearly relevant for air pollution control policy.
Specific attention to motorized traffic emissions is import-
ant because (road) traffic is an important source ofambient air pollution. More work on coarse particles and
at the other side of the particle size spectrum, ultrafine
particles is needed. Ongoing new research in the USA in
the Multi-Ethnic study of Atherosclerosis and Air pollu-
tion (MESA-AIR) and the European Study of Cohorts for
Air Pollution Effects (ESCAPE) that use large cohorts and
state-of the art spatially-resolved exposure methods will
likely contribute significant new answers in the near future
to these questions.
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